Alzheimer's disease and glaucoma: Mechanistic similarities and differences

Journal of Glaucoma

Volumn 22, Issue 5 SUPPL.1, 2013, Pages

  Ghiso, Jorge A ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

AGE; ALZHEIMER DISEASE; CELL DEATH; CONFERENCE PAPER; DISEASE SEVERITY; GLAUCOMA; HUMAN; NERVE CELL DEGENERATION; PRIORITY JOURNAL; PSEUDOEXFOLIATION; RETINA GANGLION CELL; VISION TEST;

ALZHEIMER DISEASE; DISEASE PROGRESSION; GLAUCOMA; HUMANS; OXIDATIVE STRESS; RETINAL GANGLION CELLS;

EID: 84879810506     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3182934af6     Document Type: Conference Paper

References (20)

1. Shields MB, Ritch R, Krupin T. Classification and mechanisms of the glaucomas. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. Chapter 40. St. Louis: CV Mosby Co; 1989.
2. Yucel YH, Zhang Q, Gupta N, et al. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol. 2000;118:378-384.
3. Yucel YH, Zhang Q, Weinreb RN, et al. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleous and visual cortex in glaucoma. Prog Retin Eye Res. 2003;22:465-481.
4. Rostagno A, Holton JL, Lashley T, et al. Cerebral amyloidosis: Amyloid subunits, mutants and phenotypes. Cell Mol Life Sci. 2010;67:581-600.
5. Rostagno A, Lal R, Ghiso J. Protein misfolding, aggregation, and fibril formation: Common features of cerebral and noncerebral amyloid diseases. In: Dawbarn D, Allen S, eds. The Neurobiology of Alzheimer's disease. Oxford, United Kingdom: Oxford University Press; 2007:133-160.
6. Kirby E, Bandelow S, Hogervorst E. Visual impairment in Alzheimer's disease: A critical review. J Alzheimer's Dis. 2010; 21:15-34.
7. Gupta N, Ang LC, Noel de Tilly L, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006;90:674-678.
8. Halliday G, Lees A, Stern M. Milestones in Parkinson's disease-clinical and pathologic features. Mov Disord. 2011; 26:1015-1021.
9. Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer's disease. Acta Neuropathol. 2009; 118:5-36.
10. Gupta N, Yucel YH. Glaucoma as a neurodegenerative disease. Curr Opinion Opththalmol. 2007;18:110-114.
11. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18:39-57.
12. Ray K, Mookherjee S. Molecular complexity of primary open angle glaucoma: Current concepts. J Genet. 2009;88:451-467.
13. Nakamura T, Lipton SA. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: Potential implications for Alzheimer's and Parkinson's diseases. Apoptosis. 2010;15:1354-1363.
14. Gorman AM. Neuronal cell death in neurodegenerative diseases: Recurring themes around protein handling. J Cell Mol Med. 2008;12:2263-2280.
15. Nunomura A, Moreira PI, Lee HG, et al. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets. 2007;6:411-423.
16. Sultana R, Perluigi M, Butterfield DA. Protein oxidation and lipid peroxidation in brain subjects with Alzheimer's disease: Insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal. 2006;8:2021-2037.
17. Sonkusare SK, Kaul CL, Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders - memantine, a new hope. Pharmacol Res. 2005;51:1-17.
18. Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem. 2007;101:1172-1184.
19. Ovodenko B, Rostagno A, Neubert TA, et al. Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci. 2007;48:1447-1457.
20. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.